{"entity":{"type":"insider","cik":"0001406302","url":"/insider/0001406302","json_url":"/insider/0001406302.json","name":"Lebovits Chaim","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":8,"first":"2024-07-31","last":"2024-10-02","span_basis":"filed_date"},"name_variants":[{"name":"Lebovits Chaim","source":"filing","n_filings":8,"first_seen":"2024-07-31","last_seen":"2024-10-02"}],"transactions":[{"id":2086240,"accession":"0001104659-24-105215","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-105215","line_url":"/filing/0001104659-24-105215#line-2","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001406302","owner_name":"Lebovits Chaim","owner_display_name":"Lebovits Chaim","owner_url":"/insider/0001406302","role":"Officer (President & CEO)","role_mark":"O","role_mark_label":"Officer (President & CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1836.0,"shares_display":"1,836","price_per_share":3.4272,"price_display":"3.43","price_state":"stated","total_value":6292.3392,"total_display":"6,292.34","total_whole":"6,292","shares_owned_after":80960.0,"shares_owned_after_display":"80,960","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-01","filed_date":"2024-10-02","scope":"insider"},{"id":2086227,"accession":"0001104659-24-105215","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-105215","line_url":"/filing/0001104659-24-105215#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001406302","owner_name":"Lebovits Chaim","owner_display_name":"Lebovits Chaim","owner_url":"/insider/0001406302","role":"Officer (President & CEO)","role_mark":"O","role_mark_label":"Officer (President & CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22000.0,"shares_display":"22,000","price_per_share":0.228,"price_display":"0.23","price_state":"stated","total_value":5016.0,"total_display":"5,016.00","total_whole":"5,016","shares_owned_after":1186865.0,"shares_owned_after_display":"1,186,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-30","filed_date":"2024-10-02","scope":"insider"},{"id":9223884,"accession":"0001104659-24-084344","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-084344","line_url":"/filing/0001104659-24-084344#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001406302","owner_name":"Lebovits Chaim","owner_display_name":"Lebovits Chaim","owner_url":"/insider/0001406302","role":"Officer (President & CEO)","role_mark":"O","role_mark_label":"Officer (President & CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.5183,"price_display":"0.52","price_state":"stated","total_value":7774.5,"total_display":"7,774.50","total_whole":"7,775","shares_owned_after":1164865.0,"shares_owned_after_display":"1,164,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-28","filed_date":"2024-07-31","scope":"insider"},{"id":9223882,"accession":"0001104659-24-084343","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-084343","line_url":"/filing/0001104659-24-084343#line-2","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001406302","owner_name":"Lebovits Chaim","owner_display_name":"Lebovits Chaim","owner_url":"/insider/0001406302","role":"Officer (President & CEO)","role_mark":"O","role_mark_label":"Officer (President & CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.64,"price_display":"0.64","price_state":"stated","total_value":16000.0,"total_display":"16,000.00","total_whole":"16,000","shares_owned_after":1149865.0,"shares_owned_after_display":"1,149,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-22","filed_date":"2024-07-31","scope":"insider"},{"id":9223883,"accession":"0001104659-24-084343","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-084343","line_url":"/filing/0001104659-24-084343#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001406302","owner_name":"Lebovits Chaim","owner_display_name":"Lebovits Chaim","owner_url":"/insider/0001406302","role":"Officer (President & CEO)","role_mark":"O","role_mark_label":"Officer (President & CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.579,"price_display":"0.58","price_state":"stated","total_value":14475.0,"total_display":"14,475.00","total_whole":"14,475","shares_owned_after":1124865.0,"shares_owned_after_display":"1,124,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-21","filed_date":"2024-07-31","scope":"insider"},{"id":9223880,"accession":"0001104659-24-084341","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-084341","line_url":"/filing/0001104659-24-084341#line-3","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001406302","owner_name":"Lebovits Chaim","owner_display_name":"Lebovits Chaim","owner_url":"/insider/0001406302","role":"Officer (President & CEO)","role_mark":"O","role_mark_label":"Officer (President & CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.49,"price_display":"0.49","price_state":"stated","total_value":4900.0,"total_display":"4,900.00","total_whole":"4,900","shares_owned_after":1099865.0,"shares_owned_after_display":"1,099,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-13","filed_date":"2024-07-31","scope":"insider"},{"id":9223879,"accession":"0001104659-24-084341","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-084341","line_url":"/filing/0001104659-24-084341#line-2","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001406302","owner_name":"Lebovits Chaim","owner_display_name":"Lebovits Chaim","owner_url":"/insider/0001406302","role":"Officer (President & CEO)","role_mark":"O","role_mark_label":"Officer (President & CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.4665,"price_display":"0.47","price_state":"stated","total_value":4665.0,"total_display":"4,665.00","total_whole":"4,665","shares_owned_after":1089865.0,"shares_owned_after_display":"1,089,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-11","filed_date":"2024-07-31","scope":"insider"},{"id":9223881,"accession":"0001104659-24-084341","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-084341","line_url":"/filing/0001104659-24-084341#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001406302","owner_name":"Lebovits Chaim","owner_display_name":"Lebovits Chaim","owner_url":"/insider/0001406302","role":"Officer (President & CEO)","role_mark":"O","role_mark_label":"Officer (President & CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.465,"price_display":"0.46","price_state":"stated","total_value":9300.0,"total_display":"9,300.00","total_whole":"9,300","shares_owned_after":1079865.0,"shares_owned_after_display":"1,079,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-10","filed_date":"2024-07-31","scope":"insider"},{"id":9223878,"accession":"0001104659-24-084339","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-084339","line_url":"/filing/0001104659-24-084339#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001406302","owner_name":"Lebovits Chaim","owner_display_name":"Lebovits Chaim","owner_url":"/insider/0001406302","role":"Officer (President & CEO)","role_mark":"O","role_mark_label":"Officer (President & CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":66300.0,"shares_display":"66,300","price_per_share":0.3743,"price_display":"0.37","price_state":"stated","total_value":24816.09,"total_display":"24,816.09","total_whole":"24,816","shares_owned_after":1059865.0,"shares_owned_after_display":"1,059,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-07","filed_date":"2024-07-31","scope":"insider"},{"id":9223877,"accession":"0001104659-24-084337","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-084337","line_url":"/filing/0001104659-24-084337#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001406302","owner_name":"Lebovits Chaim","owner_display_name":"Lebovits Chaim","owner_url":"/insider/0001406302","role":"Officer (President & CEO)","role_mark":"O","role_mark_label":"Officer (President & CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":135000.0,"shares_display":"135,000","price_per_share":0.3753,"price_display":"0.38","price_state":"stated","total_value":50665.5,"total_display":"50,665.50","total_whole":"50,666","shares_owned_after":993565.0,"shares_owned_after_display":"993,565","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-06","filed_date":"2024-07-31","scope":"insider"},{"id":9223876,"accession":"0001104659-24-084336","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-084336","line_url":"/filing/0001104659-24-084336#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001406302","owner_name":"Lebovits Chaim","owner_display_name":"Lebovits Chaim","owner_url":"/insider/0001406302","role":"Officer (President & CEO)","role_mark":"O","role_mark_label":"Officer (President & CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.5199,"price_display":"0.52","price_state":"stated","total_value":7798.5,"total_display":"7,798.50","total_whole":"7,799","shares_owned_after":858565.0,"shares_owned_after_display":"858,565","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-19","filed_date":"2024-07-31","scope":"insider"},{"id":9223874,"accession":"0001104659-24-084334","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-084334","line_url":"/filing/0001104659-24-084334#line-2","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001406302","owner_name":"Lebovits Chaim","owner_display_name":"Lebovits Chaim","owner_url":"/insider/0001406302","role":"Officer (President & CEO)","role_mark":"O","role_mark_label":"Officer (President & CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":115072.0,"shares_display":"115,072","price_per_share":0.5255,"price_display":"0.53","price_state":"stated","total_value":60470.336,"total_display":"60,470.34","total_whole":"60,470","shares_owned_after":843565.0,"shares_owned_after_display":"843,565","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-18","filed_date":"2024-07-31","scope":"insider"},{"id":9223875,"accession":"0001104659-24-084334","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-084334","line_url":"/filing/0001104659-24-084334#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001406302","owner_name":"Lebovits Chaim","owner_display_name":"Lebovits Chaim","owner_url":"/insider/0001406302","role":"Officer (President & CEO)","role_mark":"O","role_mark_label":"Officer (President & CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":130000.0,"shares_display":"130,000","price_per_share":0.5457,"price_display":"0.55","price_state":"stated","total_value":70941.0,"total_display":"70,941.00","total_whole":"70,941","shares_owned_after":728493.0,"shares_owned_after_display":"728,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-17","filed_date":"2024-07-31","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":13,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001137883","name":"BRAINSTORM CELL THERAPEUTICS INC.","url":"/issuer/0001137883","role":"Officer (President & CEO)","n_filings":8,"first_seen":"2024-07-31","last_seen":"2024-10-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001406302","retrieved_at":"2026-08-25T19:08:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}